Align Technology, Inc.
General ticker "ALGN" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $12.7B (TTM average)
Align Technology, Inc. does not follow the US Stock Market performance with the rate: -1.5%.
Estimated limits based on current volatility of 1.2%: low 161.74$, high 165.83$
Factors to consider:
- Earnings expected soon, date: 2026-02-04 amc
- Company included in S&P500 list
- Total employees count: 20945 (-3.1%) as of 2024
- US accounted for 42.4% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Economic downturns and volatility, Regulatory and compliance, Supply chain disruptions, Cybersecurity threats, Geopolitical risks
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [168.04$, 269.75$]
- 2025-12-31 to 2026-12-31 estimated range: [172.65$, 274.44$]
Financial Metrics affecting the ALGN estimates:
- Negative: with PPE of 22.6 at the end of fiscal year the price was high
- Positive: 7.61 < Operating profit margin, % of 15.31
- Positive: Return on assets ratio (scaled to [-100,100]) of 6.35 > 6.11
- Positive: -4.43 < Investing cash flow per share per price, % of -1.61
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Negative: Inventory ratio change, % of 1.30 > 0.79
Short-term ALGN quotes
Long-term ALGN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $3,734.64MM | $3,862.26MM | $3,968.04MM |
| Operating Expenses | $3,092.04MM | $3,218.92MM | $3,360.42MM |
| Operating Income | $642.60MM | $643.34MM | $607.63MM |
| Non-Operating Income | $-43.54MM | $-2.13MM | $1.33MM |
| R&D Expense | $305.26MM | $346.83MM | $364.20MM |
| Income(Loss) | $599.06MM | $641.20MM | $608.96MM |
| Taxes | $237.48MM | $196.15MM | $187.60MM |
| Profit(Loss)* | $361.57MM | $445.05MM | $421.36MM |
| Stockholders Equity | $3,601.36MM | $3,630.49MM | $3,851.99MM |
| Inventory | $338.75MM | $296.90MM | $254.29MM |
| Assets | $5,947.95MM | $6,083.88MM | $6,214.60MM |
| Operating Cash Flow | $568.73MM | $785.78MM | $738.23MM |
| Capital expenditure | $291.90MM | $177.72MM | $115.58MM |
| Investing Cash Flow | $-213.32MM | $-195.94MM | $-254.91MM |
| Financing Cash Flow | $-501.69MM | $-598.34MM | $-355.72MM |
| Earnings Per Share** | $4.62 | $5.82 | $5.63 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.